Interacting Drugs |
Etodolac vs Bisphosphonate Derivatives |
Security Level |
 |
Mechanism |
Bisphosphonate Derivatives: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Bisphosphonate Derivatives. Both an increased risk of gastrointestinal ulceration and an increased risk of nephrotoxicity are of concern. |
Management |
Monitor therapy |
Etodolac vs Bisphosphonate Derivatives
Post Review about Etodolac vs Bisphosphonate Derivatives Click here to cancel reply.
Other Interactions of Etodolac
Other Interactions of Bisphosphonate Derivatives
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.